SNYDER MARK HOWARD (SVP, General Counsel) exercised options at HALOZYME THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 1/6/2026ACC: 0001159036-26-000005
Officer· SVP, General Counsel
Since Jan 2022
-4.24K
Net shares
Net seller
$298.3K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
7.61K acquired · 11.85K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+7.61K
Price / share
—
Trade value
—
% of position
24.7%
1/3/2026
30.81K→38.42K
Common Stock
Direct
Shares
−4.24K
Price / share
$70.31
Trade value
$298.33K
% of position
11.0%
1/3/2026
38.42K→34.18K
Total
Net shares
+3.37K
Net value
-$298.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/3/2026 | M · Option Exercise | +7.61K | — | — | 24.7% | 30.81K | 38.42K |
| Common Stock Direct | 1/3/2026 | F · Tax Withholding | −4.24K | $70.31 | $298.33K | 11.0% | 38.42K | 34.18K |
| Total | +3.37K | -$298.33K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
7.61K shares
Shares
−7.61K
Strike price
0
Held after
0.00
Exercisable
—
1/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock7.61K shares | 1/3/2026 | M · Option Exercise | −7.61K | 0 | — | 0.00 |